Back HIV Treatment Search for a Cure

Search for a Cure

CROI 2012: Zinc Finger HIV Gene Therapy Moves Ahead

Further good news was presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle regarding SB-728-T, the Sangamo zinc finger nuclease HIV gene therapy currently in Phase 2 development.

Read more:

CROI 2012: Vorinostat -- A First Step on the Road Towards a Cure for HIV

Researchers from the University of North Carolina at Chapel Hill have for the first time shown that HIV can be purged from resting latent T-cells, an important early step in moving research forward on one of the potential HIV cure strategies, according to a report at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last week in Seattle.alt

Read more:

CROI 2012: HIV Cure Research -- A New Era of Treatment [VIDEO]

Researchers presented several studies aimed at eradication or functional cure of HIV on Thursday at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle.alt

Read more:

Coverage of the 2012 Conference on Retroviruses and Opportunistic Infections

HIVandHepatitis.com's complete coverage of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), March 5-8, 2012.

Featuring new HIV drugs, HIV cure research, biomedical prevention, HIV-related conditions and complications, basic science, hepatitis C, and HIV/HCV coinfection.

Full listing by topic

HIVandHepatitis.com CROI 2012 section

3/16/12

alt

 

Conference on Retroviruses and Opportunistic Infections Opens Next Week in Seattle

The 19th Conference on Retroviruses and Opportunistic Infections -- better known as the Retrovirus conference or CROI -- will take place next week, March 5-8, at the Washington State Convention Center in Seattle. HIVandHepatitis.com will be on site to provide breaking news, analysis, and video coverage.alt

Read more: